Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

KPRX Kiora Pharmaceuticals Inc

3,22

-0,13 (-3,88%)

28 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Kiora Pharmaceuticals (NASDAQ:KPRX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Kiora Pharmaceuticals Charts.

Kiora Pharmaceuticals (NASDAQ:KPRX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Kiora Pharmaceuticals Charts.

News Kiora Pharmaceuticals Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 12 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 20 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 15 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 9 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 9 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 30 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 14 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 14 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Kiora Pharmaceuticals Inc News-Artikel

Deutsche Telekom

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen